# Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial)

Study · id `cardio:ct-nct04523649` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04523649](<https://clinicaltrials.gov/study/NCT04523649>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04523649

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1740 participants.

## Technical summary

Registry record NCT04523649. Randomized; single masking; primary purpose screening. Start 2022-06-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 1740 participants (planned count; ClinicalTrials.gov record NCT04523649, source copy `cardio:ctgov-nct04523649-2022-03-15`, retrieved 2026-10-26)
- Planned start: 2022-06-01 (anticipated) (ClinicalTrials.gov record NCT04523649, source copy `cardio:ctgov-nct04523649-2022-03-15`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT04523649, source copy `cardio:ctgov-nct04523649-2022-03-15`, retrieved 2026-10-26)
- Completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT04523649, source copy `cardio:ctgov-nct04523649-2022-03-15`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04523649-2022-03-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial)
- Acronym: HUA-TUO
- Condition: Stroke, Cardiovascular
- Intervention (Device): Remote atrial fibrillation screening with handheld single lead ECG recorder
- Lead sponsor: The University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: The University of Hong Kong (`cardio:org-the-university-of-hong-kong`)

## Provenance

Content hash: fccdde5ef5ea38c81263a00cd0e7a98b6c62e0601ff675b3015d0fe982e099c7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
